A phase 3 randomized controlled study evaluating the efficacy and sagety of GS-1101 (CAL-101) in combination with oxfatumumab for previously treated chronic lymphocytic leukemia

  • Schwarer, Anthony (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/12 → 31/03/14